HoldsUp

DavidPerlmutterMD · 2025-04-21 · David Perlmutter (host), Steven Gundry

The Gut-Brain Paradox: Secrets To Restoring Health | Steven Gundry

35 research-tied claims examined: 8 contradicted 4 overstated 4 context 15 supported 4 unverified

8

Contradicted by research

0:02:02David Perlmutter (host)contradictedhigh

Dr. Steven Gundry has published more than 300 articles in peer-reviewed journals on using diet and supplements to eliminate heart disease, diabetes, and autoimmune conditions.

"And he's written more than 300 articles published in peer-reviewed journals on using diet and supplements to eliminate heart disease, diabetes, autoimmune conditions, and multiple other diseases." (said at 0:02:02)

While Dr. Steven R. Gundry has an extensive publication record in peer-reviewed journals from his career as a cardiothoracic surgeon, his published peer-reviewed research focuses on surgical techniques, myocardial protection, pediatric cardiac transplantation, xenotransplantation, and surgical adhesives—not dietary or supplement interventions for eliminating heart disease, diabetes, or autoimmune conditions. A comprehensive search of the peer-reviewed medical literature identifies no body of over 300 peer-reviewed studies by Gundry investigating diet and supplements for disease elimination.

0:18:25Steven Gundrycontradictedmoderate

Approximately 80% of human immune cells (white blood cells) reside in the gut.

"And you know 80% of our immune cells, our white blood cells, are down in our gut." (said at 0:18:25)

While the gastrointestinal tract is a major immunological site containing substantial mucosal-associated lymphoid tissue (and produces a large fraction of secretory antibodies such as IgA), the claim that 80% of all immune cells (white blood cells) reside in the gut is contradicted by quantitative anatomical cell surveys. Comprehensive mapping of immune cells in the human body shows that the majority of human white blood cells reside in the bone marrow (most neutrophils and precursors) and secondary lymphoid tissues such as the spleen and lymph nodes (the majority of lymphocytes), with the gut housing only a modest fraction (under 5–10%) of total immune cells.

0:26:50Steven Gundrycontradictedhigh

Glyphosate (Roundup) was originally patented as an antibiotic rather than as an herbicide.

"And Roundup was patented as an antibiotic. It wasn't a weed killer." (said at 0:26:50)

The claim that glyphosate (Roundup) was originally patented as an antibiotic rather than an herbicide is contradicted by historical patent records and chemical literature. Glyphosate was first synthesized in 1950 by Swiss chemist Henri Martin at Cilag, where it was investigated as a metal chelating agent (and patented as such under Swiss Patent CH377080, later US Patent 3,160,632). Its herbicidal properties were discovered in 1970 by John E. Franz at Monsanto, leading to its registration and original patent as a broad-spectrum herbicide (US Patent 3,799,758, issued in 1974). Monsanto later obtained a patent for its antimicrobial properties in 2010 (US Patent 7,771,736), decades after its initial synthesis as a chelator and its development and marketing as an herbicide. While glyphosate does possess antimicrobial properties by inhibiting the shikimate pathway in susceptible bacteria (PMID: 41953436, PMID: 42041382), it was not originally patented or developed as an antibiotic.

0:27:20Steven Gundrycontradictedhigh

Selective serotonin reuptake inhibitors (SSRIs) exert their clinical therapeutic effects by altering the gut microbiome to a favorable tryptophan-pathway microbiome rather than by blocking brain serotonin reuptake.

"And lo and behold, we now know that these drugs actually change the microbiome to a more favorable um tryptophan pathway microbiome. And so even these drugs, the effect was actually on the microbiome." (said at 0:27:20)

Selective serotonin reuptake inhibitors (SSRIs) exert their primary therapeutic effects by binding to and inhibiting the serotonin transporter (SERT) in the central nervous system, increasing synaptic serotonin concentration and downstream neuroplasticity. While recent research demonstrates that SSRIs can alter gut microbiota composition and downstream tryptophan/indole metabolites (PMID 31273200, PMID 40176389), and that baseline microbiome composition correlates with treatment response (PMID 39695082), these gut interactions are modulating or secondary effects. Evidence regarding the microbiota-gut-brain axis in psychotropic drug response remains heterogeneous and largely associative (PMID 42316492). Claiming that the therapeutic effect of SSRIs is "actually on the microbiome" rather than central serotonin reuptake inhibition contradicts established neuropharmacology.

0:45:30David Perlmutter (host)contradictedhigh

Traditional Inuit populations, who historically had virtually no access to plant fiber and consumed exclusively meat and fat from hunted mammals, had very low rates of coronary artery disease.

"Well, I think another example of course would be the Inuit who don't have any access to fiber or traditionally traditionally until recently, and uh would eat nothing but fat and and meat uh from the mammals that they would kill and uh you know the my understanding is that their rates of coronary vascular disease, coronary artery disease, were very, very low." (said at 0:45:30)

The host claims that traditional Inuit populations, who ate predominantly animal meat and fat with virtually no plant fiber, had very low rates of coronary artery disease (CAD). However, published epidemiological reviews and historical research demonstrate that this widely repeated narrative is a myth. A comprehensive review of 40 years of published evidence on cardiovascular disease among Inuit populations (Fodor et al., 2014) showed that Greenland, Canadian, and Alaskan Inuit populations historically experienced rates of coronary artery disease similar to or higher than non-Inuit Caucasian control populations. Furthermore, Bang and Dyerberg's seminal 1970s studies, which popularized the idea of a lower prevalence of CAD, never actually measured CAD incidence or prevalence directly; instead, they relied on official death certificates, which severely underreported causes of death in isolated populations. Additionally, CT imaging studies performed on 16th-century Inuit mummies preserved in Greenland (Wan et al., 2019) confirm the presence of vascular calcification and atherosclerosis prior to modern Western dietary influences.

0:59:06Steven Gundrycontradictedhigh

The pharmaceutical company Eli Lilly was founded as a bacteriophage company prior to the antibiotic era.

"Eli Lilly, believe it or not, started as a bacteriophage company before the times of antibiotics." (said at 0:59:06)

Eli Lilly and Company was not founded as a bacteriophage company. The company was founded in May 1876 by Colonel Eli Lilly to manufacture standardized pharmaceutical preparations and medications—decades before bacteriophages were even discovered by Frederick Twort (1915) and Félix d'Hérelle (1917). While Eli Lilly did manufacture and commercialize bacteriophage biological products (such as Colo-lysate and Staphylo-lysate) in the 1930s during the pre-antibiotic era before abandoning them when chemical antibiotics emerged, it did not start as a bacteriophage enterprise.

0:51:20Steven Gundrycontradictedhigh

Color vision exists exclusively in fruit-eating animals.

"interestingly enough, uh we're fruit predators, uh and only fruit predators have color vision—um us and great apes and bees and uh so on, hummingbirds." (said at 0:51:20)

The claim that color vision exists exclusively in fruit-eating animals is contradicted by evolutionary biology and comparative visual physiology. Color vision is widespread across the animal kingdom across diverse trophic niches, including carnivores, insectivores, and aquatic predators. Ancestral vertebrates possessed multiple cone photoreceptor types enabling tetrachromatic or pentachromatic color vision, which is preserved in many modern fish, amphibians, reptiles, and birds. While the re-evolution of trichromatic color vision in catarrhine primates is hypothesized to have been influenced by foraging for ripe fruit and tender leaves, most non-frugivorous vertebrates and many non-frugivorous invertebrates (such as predatory mantis shrimp, jumping spiders, and nectar-feeding bees and hummingbirds) possess well-developed color vision.

  • contradicts: Early evolution of vertebrate photoreception: lessons from lampreys and lungfishes. (Integrative zoology 2009) · cited 12x in the literature
    "Detailed ultrastructural analysis reveals that all five receptor types in G. australis are cone-like, whereas N. forsteri possesses four cone types and a single type of rod. Each receptor type also contains a different visual pigment (opsin gene); that is, LWS, SWS1, SWS2, RhA and RhB in G. australis and LWS, SWS1, SWS2, Rh1 and Rh2 in N. forsteri, all of which are expressed within the retina and are sensitive to different parts of the electromagnetic spectrum, providing the potential for pentachromatic and tetrachromatic color vision, respectively." (abstract, results, passage verified)
    pubmedfull study (doi)
  • contradicts: Diverse Cell Types, Circuits, and Mechanisms for Color Vision in the Vertebrate Retina. (Physiological reviews 2019) · cited 173x in the literature
    "We review studies concerning the circuit mechanisms mediating opponent interactions in a range of species, from tetrachromatic fish with diverse color opponent cell types to common dichromatic mammals where cone opponency is restricted to a subset of specialized circuits. Distinct among mammals, primates have reinvented trichromatic color vision using novel strategies to incorporate evolution of an additional photopigment gene into the foveal structure and circuitry that supports high-resolution vision." (abstract, results, passage verified)
    pubmedfull study (doi)
1:04:22David Perlmutter (host)contradictedmoderate

Akkermansia muciniphila requires butyrate to function, which is why probiotic formulations pair it with Clostridium butyricum.

"It's one of the reasons is it requires butyrate, and that's why you do see products that not only have the Akkermansia, but Clostridium butyricum to to prime the pump, as it were." (said at 1:04:22)

The claim that Akkermansia muciniphila *requires* butyrate to function is contradicted by established microbiological evidence. A. muciniphila is a mucin-degrading specialist that utilizes host mucus glycoproteins (producing acetate and propionate) and can grow autonomously on mucin without external butyrate. In cross-feeding dynamics, A. muciniphila typically liberates mucin sugars (such as fucose and sialic acid) that support butyrate-producing commensals like Clostridia, rather than having an obligate metabolic requirement for butyrate. While in vitro and murine data indicate that butyrate or Clostridium butyricum metabolites can promote or enhance A. muciniphila growth, and commercial multi-strain synbiotic formulations (such as Pendulum Therapeutics' WBF-011) combine A. muciniphila and C. butyricum to synergistically restore mucin turnover and butyrate production, this co-formulation is based on complementary functional niches rather than an obligate dependency of A. muciniphila on butyrate.

4

Overstated

0:26:40Steven Gundryoverstatedlow

Glyphosate selectively kills gut bacteria responsible for the tryptophan pathway.

"And then to come to find out that these tryptophan pathway bacteria are selectively killed by glyphosate, the active ingredient in Roundup." (said at 0:26:40)

Glyphosate inhibits 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), an enzyme in the shikimate pathway used by plants and some microorganisms to synthesize aromatic amino acids, including tryptophan. However, stating that bacteria responsible for this pathway are 'selectively killed' in the gut overstates the evidence. Metagenomic and metatranscriptomic analyses of the human gut microbiome demonstrate that most gut bacterial species lack a complete shikimate pathway, rely on dietary aromatic amino acids (auxotrophy), or carry glyphosate-insensitive (class II) EPSPS enzymes, making them largely unaffected. Furthermore, while in vivo rodent studies confirm that glyphosate can inhibit the EPSPS enzyme in the gut (evidenced by the accumulation of shikimic acid in the caecum), this enzymatic inhibition does not cause a selective kill-off or major depletion of the microbial community.

0:27:40Steven Gundryoverstatedvery low

Fecal microbiota transplants from depressed human donors into healthy rats induce depressive behavior in the rats, and transplants from healthy humans into depressed rats reverse their depression.

"And we know from animal experiments that we can take a happy rat and have it eat poop from a depressed individual and the rat will become depressed. Uh we joke rats love to eat poop. So and and conversely we can take a happy people's microbiome and have a depressed rat eat that and they'll become happy." (said at 0:27:40)

Preclinical animal research demonstrates that fecal microbiota transplantation (FMT) from humans diagnosed with major depressive disorder into microbiota-depleted rodents induces depressive-like and anxiety-like behaviors (such as anhedonia) as well as altered tryptophan metabolism (PMID: 27491067). However, the claim oversimplifies and overstates the literature in several ways: the experiments involve oral gavage into antibiotic-depleted or germ-free rodent models rather than animals freely eating feces to transfer phenotypes, and while healthy human microbiota transfers have been used as non-depressed control baselines, evidence showing complete reversal or 'curing' of pre-existing depression in rodents by transplanting healthy human microbiota is considerably more preliminary and conditional. Evidence is restricted to rodent models, yielding very low certainty for human clinical relevance.

0:30:32Steven Gundryoverstatedlow

Human studies in alcohol rehabilitation show that individuals with the most dysbiotic gut microbiome have the highest rates of treatment failure, whereas those with the least dysbiotic microbiome have the best outcomes.

"there's actually beautiful work in human studies with alcohol uh rehab. People who have the most dysbiotic alcohol seeking microbiome are the biggest failures in treatment and the people who have the least alcohol seeking microbiome are the best chances to make it through." (said at 0:30:32)

Clinical studies (notably seminal work by Leclercq et al., 2014) have demonstrated an association between gut microbiota dysbiosis, increased intestinal permeability, and higher psychological markers of relapse risk (such as elevated alcohol craving, depression, and anxiety) in alcohol-dependent patients undergoing short-term rehabilitation/detoxification. However, characterizing this as definitive proof that an 'alcohol-seeking microbiome' dictates treatment failure versus success overstates the findings. The available human research primarily evaluates surrogate psychological markers (craving and negative affect during early abstinence) in small observational cohorts rather than long-term clinical treatment failure or relapse endpoints, and the label 'alcohol seeking microbiome' is an oversimplification of complex dysbiotic shifts.

0:37:05Steven Gundryoverstatedlow

Most motorcycle accident victims are infected with Toxoplasma gondii.

"And what's really wild is that most most motorcycle accident victims are infected with toxoplasmosis." (said at 0:37:05)

While observational studies and meta-analyses have found a statistically significant association between latent Toxoplasma gondii infection and an increased risk of traffic accidents (with pooled odds ratios around 1.69 and a population attributable fraction around 17%), it is not true that "most" motorcycle or traffic accident victims are infected. Studies specifically evaluating motorcycle crash victims report seroprevalence rates far below a majority (e.g., 12.5% in a case-control study).

4

Needs context

0:41:25Steven Gundryneeds contextmoderate

Animals that naturally produce Neu5Gc do not permit Neu5Gc into their brain because of its inflammatory properties.

"And what's interesting, even animals that have Neu5Gc will not let Neu5Gc in their brain because it is so inflammatory. Even in an animal who makes Neu5Gc, that was one big surprises to me." (said at 0:41:25)

The speaker correctly notes that animals capable of synthesizing N-glycolylneuraminic acid (Neu5Gc) suppress its expression in the brain. However, the claim that Neu5Gc is excluded from the brain specifically because of its inflammatory properties is an oversimplification or extrapolation. Research confirms that across vertebrates, Neu5Gc expression in neural tissue is suppressed to trace or undetectable levels despite being synthesized in extraneural tissues. Forced overexpression of Neu5Gc in the brains of transgenic mice causes neurodevelopmental and cognitive impairments—such as abnormal locomotor activity, impaired memory, altered axon myelination, and heightened vulnerability to certain bacterial toxins—rather than primary inflammatory brain damage. While Neu5Gc is known to trigger inflammation in humans (who lack the CMAH gene and make anti-Neu5Gc antibodies), animals that naturally synthesize Neu5Gc produce it in non-neural tissues without self-directed inflammatory reactions. The evolutionary suppression of Neu5Gc in the brain appears driven by its negative impacts on neural structural and functional integrity and pathogen vulnerability rather than intrinsic inflammatory properties within those animals.

0:44:28Steven Gundryneeds contextmoderate

The country with the longest lifespan is Andorra.

"the people with the longest uh lifespan as a country uh is Andorra, this little country between Spain and uh and France up in the hills" (said at 0:44:28)

Andorra is frequently cited among the locations with the highest life expectancies in the world (and held the top rank in historical international estimates such as earlier editions of the CIA World Factbook and US Census Bureau projections). However, comprehensive global demographic analyses from the Global Burden of Disease (GBD) study, the World Health Organization, and the United Nations generally rank countries and territories such as Monaco, Japan, Singapore, Switzerland, or Hong Kong as having the highest overall life expectancies at birth.

0:46:07Steven Gundryneeds contextmoderate

A Stanford study by the Sonnenburgs found that supplementing volunteers with inulin fiber alone did not reduce inflammatory markers or increase gut microbiome diversity, but adding fermented foods like yogurt and kefir did improve diversity and lower inflammatory markers.

"like the Sonnenburgs showed, you know, the husband and wife microbiology team at Stanford, they took volunteers and they gave them a great plant fiber, inulin, which is, you know, present in artichokes and asparagus and chicory family vegetables, Jerusalem artichokes, and they looked at inflammatory markers and they looked at gut microbiome diversity. And lo and behold, nothing changed... So then they repeated the experiment and they gave them fermented foods. In this case, it was mostly yogurts and kefir, kefirs. And lo and behold, the combination of the plant fiber plus the products of fermentation, which are postbiotics, then and only then they got improved gut microbiome diversity, and then and only then did their inflammatory markers go down." (said at 0:46:07)

The speaker accurately summarizes the core comparative findings of the 2021 Stanford study led by Justin and Erica Sonnenburg (PMID 34256014), but misdescribes the study's design and interventions. The randomized trial compared two parallel dietary arms in 36 healthy adults over 17 weeks: a high-fiber diet (averaging ~45 g/day from diverse whole plant foods, not isolated inulin supplementation) versus a high-fermented-food diet (including yogurt, kefir, fermented cottage cheese, kimchi, and kombucha). In the high-fiber arm, microbial diversity remained stable and inflammatory cytokine scores did not change overall. In contrast, the fermented-food diet steadily increased gut microbiota diversity and decreased 19 inflammatory markers. The trial was a parallel comparison of these two diets, rather than a sequential experiment testing isolated inulin followed by a combination of inulin and fermented foods.

  • context: Gut-microbiota-targeted diets modulate human immune status. (Cell 2021) · cited 1347x in the literature
    "Using a 17-week randomized, prospective study (n = 18/arm) combined with -omics measurements of microbiome and host, including extensive immune profiling, we found diet-specific effects. The high-fiber diet increased microbiome-encoded glycan-degrading carbohydrate active enzymes (CAZymes) despite stable microbial community diversity. Although cytokine response score (primary outcome) was unchanged, three distinct immunological trajectories in high-fiber consumers corresponded to baseline microbiota diversity. Alternatively, the high-fermented-food diet steadily increased microbiota diversity and decreased inflammatory markers." (abstract, results, passage verified)
    pubmedfull study (doi)
1:02:12David Perlmutter (host)needs contextlow

Plant-derived exosomes can modify human gene expression.

"the notion of plant exosomes modifying our DNA is I mean that that really talks, you know, that's food uh as information, you know, that that plant exosomes changing our gen- our life code expression is pretty uh compelling." (said at 1:02:12)

The host claims that plant-derived exosomes can modify host (human/mammal) gene expression through cross-kingdom regulation, framing food as information that alters human genetic expression. While emerging research demonstrates that plant-derived exosome-like nanoparticles (PELNs/PENs) contain microRNAs and other bioactive cargo that can be internalized by human cells and modulate host gene expression in vitro and in animal models (e.g., targeting human androgen receptor or inflammatory pathways), the phenomenon remains controversial and unproven as a routine physiological dietary mechanism in humans. Systematic reviews highlight significant controversies, issues with reproducibility, low natural systemic bioavailability, and methodological challenges in establishing that dietary plant exosomes routinely alter mammalian gene expression. Thus, while supported by preliminary cell and animal studies, the statement requires context to avoid sounding like an established rule of human physiology.

15

Supported by research

0:06:40Steven Gundrysupportedmoderate

Ignaz Semmelweis instituted handwashing in his Vienna obstetrics clinic after observing maternal sepsis following autopsies, resulting in an immediate improvement in maternal mortality rates.

"So when he became on staff, he mimicked the midwives, and he actually washed his hands and made all of his people wash their hands, and almost instantaneously his results got a whole lot better than all of his other colleagues." (said at 0:06:40)

Historical epidemiological records and modern statistical re-analyses confirm the claim. In 1847 at the Vienna General Hospital (Allgemeines Krankenhaus), Ignaz Semmelweis identified that maternal mortality from puerperal sepsis was significantly higher in Clinic 1 (where doctors and medical students examined women after performing autopsies) than in Clinic 2 (staffed by student midwives who did not conduct autopsies). Semmelweis instituted mandatory hand antisepsis with chlorinated lime solutions for all clinicians before patient examinations, which led to an immediate drop in maternal mortality from an average of over 10% (reaching ~18% in peak months) down to below 2%.

0:19:22David Perlmutter (host)supportedhigh

Drugs developed to remove beta-amyloid from the brain successfully clear beta-amyloid plaques, yet treated Alzheimer's patients continue to clinically decline.

"Well, now there have been the development of drugs that actually do a pretty good job at ridding the brain of beta-amyloid, and yet patients continue to decline." (said at 0:19:22)

Randomized controlled trials and meta-analyses confirm that newer anti-amyloid monoclonal antibodies (such as lecanemab and donanemab) achieve robust clearance of beta-amyloid plaques from the brain, yet treated patients continue to experience cognitive and functional decline. The therapy at best modestly slows the rate of clinical progression relative to placebo rather than halting, preventing, or reversing dementia.

  • supports: High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis … (Revue neurologique 2022) · cited 85x in the literature
    "Compared to those tested in previous trials of the 2010s, the common feature and novelty of these anti-amyloid immunotherapies is their ability to induce a high clearance of amyloid load, as measured with positron emission tomography, in the brain of early-stage biomarker-proven AD patients... When pooled together, the data from high-clearance anti-amyloid immunotherapies trials confirm a statistically significant clinical effect of these drugs on cognitive decline after 18 months... However, this effect remains below the previously established minimal clinically relevant values." (abstract, results, passage verified)
    pubmedfull study (doi)
  • supports: Pharmacological and Clinical Heterogeneity of Anti-Amyloid Monoclonal Antibodies in Early … (Medical sciences (Basel, Switzerland) 2026)
    "Although several agents have demonstrated the ability to reduce cerebral amyloid burden, their clinical efficacy and safety remain subjects of substantial scientific and regulatory debate... Anti-amyloid monoclonal antibodies were associated with a statistically significant slowing of clinical progression compared with placebo (pooled mean difference in CDR-SB: -0.42 points; 95% CI -0.59 to -0.25; I 2 = 78%)... Despite statistical significance, the magnitude of the pooled effect approached the lower boundary of the minimal clinically important difference reported for CDR-SB in early AD." (abstract, background and results)
    pubmedfull study (doi)
0:22:46David Perlmutter (host)supportedmoderate

Rudolph Tanzi's research demonstrated that beta-amyloid functions as an antimicrobial peptide in the brain.

"Rudolph Tanzi I think made it very clear that beta-amyloid acts as an antimicrobial peptide." (said at 0:22:46)

Research co-led by Rudolph Tanzi demonstrated that amyloid-beta (Aβ) functions as an antimicrobial peptide (AMP) in cellular, animal, and human tissue models. In 2010, Soscia, Tanzi, Moir, and colleagues demonstrated in vitro that Aβ exhibits potent antimicrobial activity against multiple common pathogens, comparable to the human AMP LL-37, and that antimicrobial activity in Alzheimer's disease brain homogenates correlated directly with Aβ levels (PMID: 20209079). In 2016, Kumar, Tanzi, Moir, and colleagues expanded this in vivo, showing that Aβ expression protects against bacterial and fungal infections in mouse and nematode models by entrapping pathogens within β-amyloid fibrils as part of the innate immune response (PMID: 27225182).

0:26:15Steven Gundrysupportedmoderate

The gut microbiota synthesize neurotransmitters, including dopamine and serotonin, as well as their precursors.

"lo and behold, we find out that it's the gut microbiome themselves that are producing these neurotransmitters or the precursors." (said at 0:26:15)

The human gut microbiota directly produces and metabolizes classical neurotransmitters, including dopamine and serotonin, as well as related neuroactive amines and precursors. Specific bacterial strains express functional enzymes, such as bacterial aromatic L-amino acid decarboxylases (AADCs), that synthesize these monoamines and regulate precursor availability (e.g., tryptophan and tyrosine) within the gut environment.

0:31:44Steven Gundrysupportedvery low

In experimental animals, depleting the gut microbiome with antibiotics significantly reduces the required dose of narcotics for an effect, and reintroducing the microbiome restores high tolerance.

"what they've done again in experimental animals, they'll wipe out this opioid seeking microbiome with antibiotics and then kind of instantly these animals a tiny dose of a narcotic is enough to give an effect. Then you reintroduce this opioid seeking microbiome and instantly, I mean the next day, they're back to, "Oh my gosh, I have I need this huge dose to have the same effect."" (said at 0:31:44)

Animal studies support the claim. In rodent models of chronic morphine administration, gut microbiota depletion using broad-spectrum antibiotic regimens or germ-free conditions significantly attenuates the development of morphine analgesic tolerance, allowing the drug to maintain antinociceptive efficacy. Furthermore, fecal microbiota transplantation or reconstitution of germ-free mice with microbiota reinstates morphine tolerance. Evidence is currently limited to preclinical animal models.

0:34:09Steven Gundrysupportedvery low

Toxoplasma gondii infection in rodents alters the dopamine pathway in the brain, causing them to be sexually excited by and attracted to the smell of cat urine.

"Toxoplasmosis goes to the brain of the rat and using the dopamine pathway simplistically rewires the brain of this advanced organism to love the smell of cat urine, to get sexually excited by cat urine and the sight of a cat, and to run to find that cat, run to danger, and of course the cat eats the rodent and the life cycle is completed." (said at 0:34:09)

Published neurobiological and behavioural research in rodent models demonstrates that Toxoplasma gondii infection shifts the rodent's innate aversion to cat odor into attraction. Specifically, neuroimaging and c-Fos mapping show that exposure to cat urine in infected male rats activates posterodorsal medial amygdala and hypothalamic pathways typically dedicated to sexual arousal/attraction rather than the classical defensive fear pathways. T. gondii infection is also documented to alter dopaminergic circuitry in the amygdala and brain tissue. Because this evidence is derived entirely from animal and mechanistic studies, the GRADE certainty is rated as very low.

0:35:25Steven Gundrysupportedlow

Most pack leaders among wolves in Yellowstone National Park are infected with Toxoplasma gondii.

"And we know in Yellowstone Park that the most of the pack leaders in Yellowstone Park are infected with toxoplasmosis. Why? Because they're willing to take risks." (said at 0:35:25)

A 26-year study of gray wolves (Canis lupus) in Yellowstone National Park published in 2022 examined the behavioral effects of Toxoplasma gondii infection. The researchers found that seropositive wolves were significantly more likely to engage in high-risk behaviors, including natal dispersal (11 times more likely) and becoming a pack leader (more than 46 times more likely than uninfected wolves). This observational cohort study supports the claim that T. gondii infection is strongly associated with pack leadership through parasite-induced risk-taking behavior.

0:40:20Steven Gundrysupportedmoderate

Consuming beef, lamb, pork, and milk containing Neu5Gc causes humans to produce aggressive antibodies against Neu5Gc and incorporate it into tissue glycocalyces, displacing Neu5Ac.

"We have a sugar molecule in us called Neu5Ac. It's also in fish and poultry. Neu5Gc and Neu5Ac look identical except for one molecule of oxygen. They're otherwise identical... When we swallow Neu5Gc, we make a very aggressive antibody to it. We hate it. What's interesting is we will incorporate Neu5Gc into our various glycocalyces and displace Neu5Ac. And the more of these foods we eat, the more it's displaced. And then we attack it as a foreign substance." (said at 0:40:20)

The speaker's statement accurately summarizes the established biochemistry and immunology surrounding Neu5Gc and Neu5Ac in humans. Neu5Gc (N-glycolylneuraminic acid) differs from endogenous human Neu5Ac (N-acetylneuraminic acid) by a single hydroxyl oxygen atom added by the CMP-Neu5Ac hydroxylase (CMAH) enzyme, which is mutated and non-functional in humans. Neu5Gc is selectively enriched in red meat (beef, pork, lamb) and dairy products, but rare in poultry and fish. When humans ingest dietary Neu5Gc, it is metabolically absorbed and incorporated into newly synthesized glycoconjugates (glycocalyx) across human tissues, displacing Neu5Ac. Because the human immune system recognizes Neu5Gc as foreign, circulating anti-Neu5Gc antibodies (IgG, IgM, IgA) are produced and target these incorporated glycans, leading to immune activation and chronic inflammation (xenosialitis).

0:52:55Steven Gundrysupportedmoderate

Humans and great apes share an evolutionary mutation that disabled the uricase gene, allowing fructose to be stored more efficiently as fat.

"And we uh we inherited the gene, the mutation that you well know about from great apes that got rid of uricase, and it allowed us like great apes to take fructose and store it as fat for the winter." (said at 0:52:55)

Evolutionary and metabolic literature establishes that hominoids (humans and great apes) share pseudogenizing mutations in the urate oxidase (uricase) gene that occurred in ancestral hominoids during the mid-Miocene (approximately 12–15 million years ago). Uricase degrades uric acid; its loss leads to higher circulating uric acid levels upon fructose ingestion, which acts as a metabolic amplifier to enhance lipogenesis and promote fat storage, thought to have provided a selective survival advantage during periods of seasonal cooling and fruit scarcity.

0:54:50Steven Gundrysupportedhigh

Dead, pasteurized Akkermansia muciniphila organisms provide significant metabolic benefits comparable to viable bacteria due to surface signaling molecules.

"And we know for instance from Akkermansia studies looking at dead Akkermansia versus living Akkermansia that dead Akkermansia literally do contain messages that are useful." (said at 0:54:50)

Preclinical and human randomized controlled trials demonstrate that non-viable, pasteurized Akkermansia muciniphila retains and in some parameters enhances its metabolic efficacy compared to live bacteria. Researchers identified that specific heat-stable outer membrane proteins, such as Amuc_1100, interact directly with host cell receptors (such as Toll-like receptor 2) to signal and trigger metabolic benefits, including improved insulin sensitivity, reduced insulinemia, and enhanced gut barrier function.

0:40:20Steven Gundrysupportedhigh

Neu5Gc (N-glycolylneuraminic acid) and Neu5Ac (N-acetylneuraminic acid) differ in chemical structure by only a single oxygen atom.

"Neu5Gc and Neu5Ac look identical except for one molecule of oxygen. They're otherwise identical." (said at 0:40:20)

N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc) differ in chemical structure by a single oxygen atom. Neu5Gc possesses an additional oxygen atom in the form of a hydroxyl group attached to the N-acetyl methyl group (forming an N-glycolyl group), a modification mediated by the enzyme CMP-N-acetylneuraminic acid hydroxylase (CMAH). Although the speaker colloquially said 'molecule of oxygen' rather than 'oxygen atom', the core statement that the two sialic acids differ chemically by a single oxygen atom is well-established.

0:44:50Steven Gundrysupportedmoderate

Toulouse has the lowest rate of coronary artery disease in France.

"And there and you know the best coronary artery disease in France is in Toulouse, the home of foie gras and sausages in cassoulet." (said at 0:44:50)

Population-based cardiovascular registry data from the WHO MONICA project in France (which systematically monitored acute coronary heart disease across three distinct regions: Lille in the north, Strasbourg in the east, and Toulouse/Haute-Garonne in the southwest) demonstrated a clear north-to-south gradient. Toulouse consistently recorded the lowest coronary heart disease mortality and case-fatality rates among the monitored French regions.

0:48:55Steven Gundrysupportedlow

Polyphenols act as mitochondrial uncouplers.

"And polyphenols actually are really good at uncoupling mitochondria. And we could spend an hour talking about that, but let's just say they're mitochondrial protective agents." (said at 0:48:55)

Preclinical and biochemical literature demonstrates that various dietary polyphenols (such as quercetin, resveratrol, and chlorogenic acid) act as mitochondrial uncouplers by dissipating the mitochondrial membrane potential via protonophore mechanisms and by inducing uncoupling proteins (e.g., UCP1). These actions are frequently associated in mechanistic studies with reduced mitochondrial reactive oxygen species production and metabolic regulation.

1:03:42Steven Gundrysupportedmoderate

Some patients have high levels of Akkermansia muciniphila in their microbiome yet fail to produce significant levels of short-chain fatty acids.

"I have a number of patients who have a lot of Akkermansia, but they don't produce doodly-squat worth of short-chain fatty acids even though that bug is in there." (said at 1:03:42)

The speaker's observation that high abundance of Akkermansia muciniphila does not necessarily correspond to high total short-chain fatty acid (SCFA) production is supported by microbiological and clinical metabolomic studies. While A. muciniphila ferments host mucin to produce acetate and propionate, overall colonic SCFA production—particularly butyrate—depends on fermentable dietary fiber intake and cross-feeding interactions with syntrophic butyrate-producing species (such as Faecalibacterium prausnitzii, Eubacterium hallii, and Anaerostipes caccae). In human cohort studies, individual taxon abundances, including A. muciniphila, do not consistently correlate with high fecal SCFA concentrations across diverse clinical phenotypes.

1:04:34David Perlmutter (host)supportedmoderate

Gut bacteria can ferment meat to produce butyrate.

"you're saying that we can ferment meat and produce butyrate." (said at 1:04:34)

Gut microbiota possess well-characterized enzymatic pathways (such as the glutamate and lysine fermentation pathways) to catabolize amino acids from undigested dietary proteins—including meat—into short-chain fatty acids, including butyrate, acetate, and propionate. Although non-digestible carbohydrates are quantitatively the predominant substrate for colonic butyrate production, proteolytic fermentation by human and animal colonic bacteria also yields butyrate alongside branched-chain fatty acids and other nitrogenous metabolites.

4

No source found (not proven false)

0:00:15Steven Gundryunverifiedvery low

Individuals with dementia have up to fourfold more bacteria in their brain compared to people without dementia.

"And one of the scary things is people, for instance, with dementia have up to fourfold more bacteria in their brain than hopefully you and I do." (said at 0:00:15)

No published record matching the claim that individuals with dementia have up to fourfold more bacteria in their brain compared to people without dementia was located; this does not prove the claim false.

0:10:12Steven Gundryunverifiedvery low

A 62-year-old female physician with severe Parkinson's disease resolved her tremors and symptoms after treatment for intestinal permeability, and subsequently experienced symptom relapse after gluten cross-contamination from a shared cutting board.

"So, this was a a young woman—young woman, 62 years old, she's a physician... who had developed uh really bad Parkinson's... we had done leaky gut tests on her... we put her on my program... she did not have a tremor... And her downhill that she felt started shortly after he arrived." (said at 0:10:12)

No published record matching the reported clinical case of a 62-year-old female physician experiencing resolution of Parkinson's disease symptoms following dietary treatment for intestinal permeability, followed by relapse attributed to gluten cross-contamination, was located; this does not prove the claim false.

0:24:18Steven Gundryunverifiedvery low

Dr. Steven Gundry's father had Parkinson's disease for 25 years without disease progression or medication adjustments while maintained on a grain-, carbohydrate-, and sugar-restricted diet, dying at age 91 of an unrelated cause.

"my father um had Parkinson's uh for about 25 years. Um and he uh when he first developed it, I was just kind of starting in this, and he was act he did not change in 25 years, did not change his medication, did not change his because I taught my mother um to feed him, I guess. Uh and and funny I'll tell you a funny story... but yeah, he did he was he had Parkinson's for 25 years and died of a totally different reason at 91." (said at 0:24:18)

No published record matching Dr. Steven Gundry's account of his father's 25-year course with Parkinson's disease or specific dietary management was located; this does not prove the claim false. Personal anecdotes and unpublished single-case observations cannot be verified against the peer-reviewed medical literature.

0:44:50Steven Gundryunverifiedvery low

Traditional fermentation of meats and sausages by lactic acid bacteria, as well as fermentation of milk, eliminates Neu5Gc.

"And these fermented sausages, traditional sausages, are fermented. They they have lactic acid bacteria in them. They eat all the Neu5Gc. So these guys are getting great fermented products that doesn't have Neu5Gc. And fermenting milk removes Neu5Gc." (said at 0:44:50)

No published record matching the claim that traditional fermentation of sausages or meats by lactic acid bacteria, or the fermentation of milk, eliminates or removes Neu5Gc was located; this does not prove the claim false. Research has demonstrated that human gut microbiota (such as specific Bacteroidales species expressing specialized sialidases) can liberate and utilize Neu5Gc in the intestine, and Neu5Gc remains detectable in fermented dairy products such as cheddar cheese. However, evidence showing that traditional lactic acid bacterial food fermentation processes degrade or eliminate Neu5Gc from meats or dairy products is lacking.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.